Locations
San Jose, CA, USA · Santa Clara, CA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Seed
founded in
2018
d Novo is a biotechnology company founded in 2018, focused on addressing hair loss by regenerating hair stem cells through their proprietary direct reprogramming technology. This innovative approach allows them to convert a small sample of a patient's skin, blood, or fat into personalized hair stem cells, effectively treating the root cause of hair loss rather than just masking the symptoms. With a team of Stanford-trained scientists, d Novo has demonstrated significant milestones, including the successful generation of human hair stem cells and the ability to promote hair growth within months of treatment. Their unique solution positions them as a potential leader in the hair restoration market, offering a permanent solution to a widespread issue.
Something looks off?